Publications
2024
Metastatic pancreatic cancer: a new standardised dose-reduction regimen?
Ghaneh, P., & Palmer, D. (2024). Metastatic pancreatic cancer: a new standardised dose-reduction regimen?. The lancet. Gastroenterology & hepatology, 9(10), 898-900. doi:10.1016/s2468-1253(24)00227-9
Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis.
Astuti, Y., Raymant, M., Quaranta, V., Clarke, K., Abudula, M., Smith, O., . . . Schmid, M. C. (2024). Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis.. Nature cancer, 5(5), 774-790. doi:10.1038/s43018-024-00731-2
Mesothelin secretion by pancreatic cancer cells co-opts macrophages and promotes metastasis
Mielgo Iza, A. (n.d.). Mesothelin secretion by pancreatic cancer cells co-opts macrophages and promotes metastasis. Cancer Research. doi:10.1158/0008-5472.CAN-23-1542
2023
Adjuvant Chemotherapy in Pancreatic Cancer
Mann, K., Jones, R. P., Ghaneh, P., & Neoptolemos, J. P. (2023). Adjuvant Chemotherapy in Pancreatic Cancer. In Unknown Book (pp. 1143-1152). Wiley. doi:10.1002/9781119876007.ch148
Adjuvant and Palliative Chemotherapy of Periampullary Cancers
Ponweera, A. D. N. R., Ghaneh, P., & Neoptolemos, J. P. (2023). Adjuvant and Palliative Chemotherapy of Periampullary Cancers. In Unknown Book (pp. 1291-1298). Wiley. doi:10.1002/9781119876007.ch164
Surveillance for Presumed BD-IPMN of the Pancreas: Stability, Size, and Age Identify Targets for Discontinuation.
Marchegiani, G., Pollini, T., Burelli, A., Han, Y., Jung, H. -S., Kwon, W., . . . Salvia, R. (2023). Surveillance for Presumed BD-IPMN of the Pancreas: Stability, Size, and Age Identify Targets for Discontinuation.. Gastroenterology, S0016-5085(23)00935-6. doi:10.1053/j.gastro.2023.06.022
ESPAC-5 and future directions
Ghaneh, P. (2023). ESPAC-5 and future directions. Pancreatology, 23(4), e3-e4. doi:10.1016/j.pan.2023.04.017
PANC Study (Pancreatitis: A National Cohort Study): national cohort study examining the first 30 days from presentation of acute pancreatitis in the UK
Kosti, A., Borakati, A., Varma, A., Gupta, A., Mustafa, A., Hakeem, A., . . . Bleything, Z. (2023). PANC Study (Pancreatitis: A National Cohort Study): national cohort study examining the first 30 days from presentation of acute pancreatitis in the UK. BJS Open, 7(3). doi:10.1093/bjsopen/zrad008
Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients With Resectable or Borderline Resectable Disease (COMM-PACT-RB) A Systematic Review and Delphi Consensus Statement
Pijnappel, E. N., Suurmeijer, J. A., Koerkamp, B. G., Kos, M., Siveke, J. T., Salvia, R., . . . van Laarhoven, H. W. M. (2023). Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients With Resectable or Borderline Resectable Disease (COMM-PACT-RB) A Systematic Review and Delphi Consensus Statement. JAMA ONCOLOGY, 8(6), 929-937. doi:10.1001/jamaoncol.2022.0168
GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinoma
de Andres, M. P., Jackson, R. J., Felipe, I., Zagorac, S., Pilarsky, C., Schlitter, A. M., . . . Real, F. X. (2023). GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinoma. GUT, 72(3), 535-548. doi:10.1136/gutjnl-2021-325803
2022
Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial.
Ghaneh, P., Palmer, D., Cicconi, S., Jackson, R., Halloran, C. M., Rawcliffe, C., . . . European Study Group for Pancreatic Cancer. (2022). Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial.. The lancet. Gastroenterology & hepatology, S2468-1253(22)00348-X. doi:10.1016/s2468-1253(22)00348-x
Evaluation of the prognostic role of aspirin and metformin in the ESPAC 4 randomised trial of adjuvant gemcitabine versus gemcitabine plus capecitabine in patients with resected pancreatic cancer
Ponweera, A., Robinson, M., Jackson, R., Halloran, C., Palmer, D., Hackert, T., . . . Ghaneh, P. (2022). Evaluation of the prognostic role of aspirin and metformin in the ESPAC 4 randomised trial of adjuvant gemcitabine versus gemcitabine plus capecitabine in patients with resected pancreatic cancer. In BRITISH JOURNAL OF SURGERY Vol. 109. doi:10.1093/bjs/znac404.107
United Kingdom Early Detection Initiative (UK-EDI): protocol for establishing a national multicentre cohort of individuals with new-onset diabetes for early detection of pancreatic cancer
Oldfield, L., Stott, M., Hanson, R., Jackson, R. J., Reynolds, W., Chandran-Gorner, V., . . . Costello, E. (2022). United Kingdom Early Detection Initiative (UK-EDI): protocol for establishing a national multicentre cohort of individuals with new-onset diabetes for early detection of pancreatic cancer. BMJ OPEN, 12(10). doi:10.1136/bmjopen-2022-068010
A Multicenter, Randomized, Double-Blinded, Clinical Trial Comparing Cattell-Warren and Blumgart Anastomoses Following Partial Pancreatoduodenectomy: PANasta Trial.
Halloran, C. M., Neoptolemos, J. P., Jackson, R., Platt, K., Psarelli, E. -E., Reddy, S., . . . Ghaneh, P. (2022). A Multicenter, Randomized, Double-Blinded, Clinical Trial Comparing Cattell-Warren and Blumgart Anastomoses Following Partial Pancreatoduodenectomy: PANasta Trial.. Annals of surgery open : perspectives of surgical history, education, and clinical approaches, 3(3), e198. doi:10.1097/as9.0000000000000198
Pre-surgical staging and surveillance after curative treatment for pancreatic ductal adenocarcinoma (PDAC): Survey of practice in the United Kingdom (UK)
Lamarca, A., Roberts, K., Graham, J., Kocher, H., Chang, D., Ghaneh, P., . . . Valle, J. (2022). Pre-surgical staging and surveillance after curative treatment for pancreatic ductal adenocarcinoma (PDAC): Survey of practice in the United Kingdom (UK). In ANNALS OF ONCOLOGY Vol. 33 (pp. S278-S279). doi:10.1016/j.annonc.2022.04.175
Treatment of unresectable locally advanced pancreatic cancer with percutaneous irreversible electroporation (IRE) following initial systemic chemotherapy (LAP-PIE) trial: study protocol for a feasibility randomised controlled trial
Rai, Z. L., Ranieri, V., Palmer, D. H., Littler, P., Ghaneh, P., Gurusamy, K., . . . Davidson, B. R. (2022). Treatment of unresectable locally advanced pancreatic cancer with percutaneous irreversible electroporation (IRE) following initial systemic chemotherapy (LAP-PIE) trial: study protocol for a feasibility randomised controlled trial. BMJ OPEN, 12(5). doi:10.1136/bmjopen-2021-050166
Diagnosis and treatment of exocrine pancreatic insufficiency in chronic pancreatitis: An international expert survey and case vignette study.
de Rijk, F. E. M., van Veldhuisen, C. L., Besselink, M. G., van Hooft, J. E., van Santvoort, H. C., van Geenen, E. J. M., . . . Dutch Pancreatitis Study Group. (2022). Diagnosis and treatment of exocrine pancreatic insufficiency in chronic pancreatitis: An international expert survey and case vignette study.. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 22(4), 457-465. doi:10.1016/j.pan.2022.03.013
Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes
Oldfield, L., Evans, A., Rao, R. G., Jenkinson, C., Purewal, T., Psarelli, E. E., . . . Costello, E. (2022). Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes. EBIOMEDICINE, 75. doi:10.1016/j.ebiom.2021.103802
Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6/AXL signalling axis
Bellomo, G., Rainer, C., Quaranta, V., Astuti, Y., Raymant, M., Boyd, E., . . . Schmid, M. C. (n.d.). Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6/AXL signalling axis. Gut. doi:10.1136/gutjnl-2021-325272
2021
hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA
Aughton, K., Elander, N. O., Evans, A., Jackson, R., Campbell, F., Costello, E., . . . Greenhalf, W. (2021). hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA. CANCERS, 13(22). doi:10.3390/cancers13225758
Optimising treatment pathways for borderline and locally advanced pancreatic cancer: an adaptive personalised approach
Radhakrishna, G., & Ghaneh, P. (2021). Optimising treatment pathways for borderline and locally advanced pancreatic cancer: an adaptive personalised approach. BRITISH JOURNAL OF CANCER, 125(9), 1179-1180. doi:10.1038/s41416-021-01416-8
Multimodality standard of care treatment of resectable and borderline resectable pancreatic cancer
Neoptolemos, J. P., Ghaneh, P., & Hackert, T. (2021). Multimodality standard of care treatment of resectable and borderline resectable pancreatic cancer. HEPATOBILIARY SURGERY AND NUTRITION, 10(5), 714-716. doi:10.21037/hbsn-21-131
Concordance of human equilibrative nucleoside transporter‐1 expressions between murine ( 10D7G2 ) and rabbit ( SP120 ) antibodies and association with clinical outcomes of adjuvant chemotherapy for pancreatic cancer: A collaborative study from the JASPAC 01 trial
Okamura, Y., Boku, N., Ghaneh, P., Greenhalf, W., Yasukawa, S., Narimatsu, H., . . . Uesaka, K. (2021). Concordance of human equilibrative nucleoside transporter‐1 expressions between murine ( 10D7G2 ) and rabbit ( SP120 ) antibodies and association with clinical outcomes of adjuvant chemotherapy for pancreatic cancer: A collaborative study from the JASPAC 01 trial. Cancer Reports. doi:10.1002/cnr2.1507
Reply to Comment on "The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic"
Jones, C. M., Radhakrishna, G., Aitken, K., Bridgewater, J., Corrie, P., Eatock, M., . . . Mukherjee, S. (2021). Reply to Comment on "The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic". BRITISH JOURNAL OF CANCER, 124(3), 679-680. doi:10.1038/s41416-020-01133-8
Cost analysis and outcomes of endoscopic, minimal access and open pancreatic necrosectomy.
Saunders, R., Hughes, F. E., Evans, J. C., Smart, H. L., Ghaneh, P., Ramesh, J., . . . Halloran, C. M. (2021). Cost analysis and outcomes of endoscopic, minimal access and open pancreatic necrosectomy.. Annals of surgery open : perspectives of surgical history, education, and clinical approaches, 2(2), e068. doi:10.1097/as9.0000000000000068
Digital quantification of GATA6 expression from immunohistochemistry is associated with overall survival after surgery for pancreatic cancer in the ESPAC trials.
Grant, R. C., Duan, K., Jackson, R., Greenhalf, W., Costello-Goldring, E., Ghaneh, P., . . . Fischer, S. (2021). Digital quantification of GATA6 expression from immunohistochemistry is associated with overall survival after surgery for pancreatic cancer in the ESPAC trials.. In CANCER RESEARCH Vol. 81. Retrieved from https://www.webofscience.com/
Single port retroperitoneal pancreatic necrosectomy for the treatment of extra-pancreatic walled off necrotic collections.
Saunders, R., Neoptolemos, J. P., Hughes, F., Ghaneh, P., & Halloran, C. M. (2021). Single port retroperitoneal pancreatic necrosectomy for the treatment of extra-pancreatic walled off necrotic collections.. Annals of surgery open : perspectives of surgical history, education, and clinical approaches, 2(1), e019. doi:10.1097/as9.0000000000000019
Verona Evidence-Based Meeting (EBM) 2020 on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: Meeting Report
Salvia, R., Marchegiani, G., Balduzzi, A., Pollini, T., Caravati, A., Maggino, L., . . . Zyromski, N. (2021). Verona Evidence-Based Meeting (EBM) 2020 on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: Meeting Report. DIGESTIVE SURGERY, 38(4), 316-322. doi:10.1159/000518190
2020
An international pragmatic randomized controlled trial to compare a single-use negative-pressure dressing versus the surgeon's preference of dressing to reduce the incidence of surgical site infection following emergency laparotomy: the SUNRRISE trial protocol
Wilkin, R., Coe, P., Duarte, R., Stott, M., Pockney, P., Egoroff, N., . . . Collaborative, W. M. R. (2021). An international pragmatic randomized controlled trial to compare a single-use negative-pressure dressing versus the surgeon's preference of dressing to reduce the incidence of surgical site infection following emergency laparotomy: the SUNRRISE trial protocol. COLORECTAL DISEASE, 23(4), 989-1000. doi:10.1111/codi.15474
GATA6 expression is prognostic after surgical resection of pancreatic cancer: results from the ESPAC trials
Grant, R. C., Duan, K., Jackson, R., Greenhalf, W., Costello-Goldring, E., Ghaneh, P., . . . Fischer, S. (2020). GATA6 expression is prognostic after surgical resection of pancreatic cancer: results from the ESPAC trials. In CANCER RESEARCH Vol. 80. doi:10.1158/1538-7445.PANCA20-PO-005
PANasta Trial: Cattell Warren Versus Blumgart Techniques of Pancreatico-Jejunostomy Following Pancreato-Duodenectomy - A Randomized Double Blind Multi-Center Trial
Halloran, C. M., Neoptolemos, J. P., Jackson, R., Reddy, S., Gomez, D., O'Reilly, D., . . . Ghaneh, P. (2020). PANasta Trial: Cattell Warren Versus Blumgart Techniques of Pancreatico-Jejunostomy Following Pancreato-Duodenectomy - A Randomized Double Blind Multi-Center Trial. In PANCREAS Vol. 49 (pp. 1411). Retrieved from https://www.webofscience.com/
PANasta Trial: Cattell Warren versus Blumgart techniques of pancreatico-jejunostomy following pancreato-duodenectomy-A double-blinded multi-centered trial, trial results.
Halloran, C., Neoptolemos, J. P., Platt, K., Jackson, R., Reddy, S., Oreily, D., . . . Ghaneh, P. (2020). PANasta Trial: Cattell Warren versus Blumgart techniques of pancreatico-jejunostomy following pancreato-duodenectomy-A double-blinded multi-centered trial, trial results.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 38. Retrieved from https://www.webofscience.com/
Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position
Jones, C. M., Radhakrishna, G., Aitken, K., Bridgewater, J., Corrie, P., Eatock, M., . . . Mukherjee, S. (2020). Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position. BRITISH JOURNAL OF CANCER, 123(5), 709-713. doi:10.1038/s41416-020-0980-x
Prognostic value of 18FDG PET-CT volumetric parameters in the survival prediction of patients with pancreatic cancer
Halloran, C. M. (n.d.). Prognostic value of 18FDG PET-CT volumetric parameters in the survival prediction of patients with pancreatic cancer. Annals of Surgical Oncology. doi:10.1016/j.ejso.2020.02.002
Management of the pancreatic transection plane after left (distal) pancreatectomy: Expert consensus guidelines by the International Study Group of Pancreatic Surgery (ISGPS)
Miao, Y., Lu, Z., Yeo, C. J., Vollmer, C. M. J., Fernandez-del Castillo, C., Ghaneh, P., . . . Buchler, M. W. (2020). Management of the pancreatic transection plane after left (distal) pancreatectomy: Expert consensus guidelines by the International Study Group of Pancreatic Surgery (ISGPS). SURGERY, 168(1), 72-84. doi:10.1016/j.surg.2020.02.018
ESPAC-4: A multicenter, international, open-label randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (GEM) and capecitabine (CAP) versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma: Five year follow-up.
Neoptolemos, J. P., Palmer, D. H., Ghaneh, P., Valle, J. W., Cunningham, D., Wadsley, J., . . . Buchler, M. W. (2020). ESPAC-4: A multicenter, international, open-label randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (GEM) and capecitabine (CAP) versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma: Five year follow-up.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 38. Retrieved from https://www.webofscience.com/
ESPAC-5F: Four Arm, Prospective, Multicenter, International Randomized Phase II Trial of Immediate Surgery Compared With Neoadjuvant Gemcitabine Plus Capecitabine (GEMCAP) or FOLFIRINOX or Chemoradiotherapy (CRT) in Patients With Borderline Resectable Pancreatic Cancer
Ghaneh, P., Palmer, D., Cicconi, S., Halloran, C. M., Jackson, R., Rawcliffe, C., . . . Neoptolemos, J. P. (2020). ESPAC-5F: Four Arm, Prospective, Multicenter, International Randomized Phase II Trial of Immediate Surgery Compared With Neoadjuvant Gemcitabine Plus Capecitabine (GEMCAP) or FOLFIRINOX or Chemoradiotherapy (CRT) in Patients With Borderline Resectable Pancreatic Cancer. In PANCREAS Vol. 49 (pp. 1410). Retrieved from https://www.webofscience.com/
GATA6 expression is prognostic after surgical resection of pancreatic cancer: results from the ESPAC trials.
Grant, R. C., Duan, K., Jackson, R., Greenhalf, W., Costello-Goldring, E., Ghaneh, P., . . . Fischer, S. (2020). GATA6 expression is prognostic after surgical resection of pancreatic cancer: results from the ESPAC trials.. In CANCER RESEARCH Vol. 80. Retrieved from https://www.webofscience.com/
2019
Response to Comment on "The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma'' by Niccolo Petrucciani, MD, PhD, FACS, Laura Antolino, MD, Giovanni Moschetta, MD, Giovanni Ramacciato, MD, FACS
Neoptolemos, J. P., Ghaneh, P., Kleeff, J., Halloran, C. M., & Büchler, M. W. (2019). Response to Comment on "The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma'' by Niccolo Petrucciani, MD, PhD, FACS, Laura Antolino, MD, Giovanni Moschetta, MD, Giovanni Ramacciato, MD, FACS. ANNALS OF SURGERY, 270(06), E130-E131. doi:10.1097/SLA.0000000000003371
The Liverpool duodenum-and spleen-preserving near-total pancreatectomy can provide long-term pain relief in patients with end-stage chronic pancreatitis
Sheel, A. R. G., Baron, R. D., Dickerson, L. D., Ghaneh, P., Campbell, F., Raraty, M. G. T., . . . Neoptolemos, J. P. (2019). The Liverpool duodenum-and spleen-preserving near-total pancreatectomy can provide long-term pain relief in patients with end-stage chronic pancreatitis. LANGENBECKS ARCHIVES OF SURGERY, 404(7), 831-840. doi:10.1007/s00423-019-01837-3
Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial
Jones, R. P., Psarelli, E. -E., Jackson, R., Ghaneh, P., Halloran, C. M., Palmer, D. H., . . . Millat, B. (2019). Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial. JAMA SURGERY, 154(11), 1038-1048. doi:10.1001/jamasurg.2019.3337
Joint Modelling for longitudinal measures of marker CA19-9 and survival data in patients with pancreatic cancer
Cicconi, S., Ghaneh, P., Neoptolemos, J., Kolamunnage-Dona, R., & Jackson, R. (2019). Joint Modelling for longitudinal measures of marker CA19-9 and survival data in patients with pancreatic cancer. In TRIALS Vol. 20. Retrieved from https://www.webofscience.com/
A systematic review and meta-analysis of metal versus plastic stents for drainage of pancreatic fluid collections: metal stents are advantageous
Saunders, R., Ramesh, J., Cicconi, S., Evans, J., Yip, V. S., Raraty, M., . . . Halloran, C. (2019). A systematic review and meta-analysis of metal versus plastic stents for drainage of pancreatic fluid collections: metal stents are advantageous. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 33(5), 1412-1425. doi:10.1007/s00464-018-6416-5
Tumour stage and resection margin status are independent survival factors following partial pancreatoduodenectomy for duodenal adenocarcinoma
Mann, K., Gilbert, T., Cicconi, S., Jackson, R., Whelan, P., Campbell, F., . . . Ghaneh, P. (2019). Tumour stage and resection margin status are independent survival factors following partial pancreatoduodenectomy for duodenal adenocarcinoma. LANGENBECKS ARCHIVES OF SURGERY, 404(4), 439-449. doi:10.1007/s00423-019-01779-w
The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma
Ghaneh, P., Kleeff, J., Halloran, C. M., Raraty, M., Jackson, R., Melling, J., . . . Smith, C. (2019). The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma. Annals of Surgery, 269(03), 520-529. doi:10.1097/SLA.0000000000002557
Differentiation of Autoimmune Pancreatitis from Pancreatic Cancer Remains Challenging
Dickerson, L. D., Farooq, A., Bano, F., Kleeff, J., Baron, R., Raraty, M., . . . Yip, V. S. (2019). Differentiation of Autoimmune Pancreatitis from Pancreatic Cancer Remains Challenging. WORLD JOURNAL OF SURGERY, 43(6), 1604-1611. doi:10.1007/s00268-019-04928-w
A multicentre investigation into the management and outcome of patients treated for Pyogenic Liver Abscess
Gilbert, T., Sheel, A., Fretwell, V., Ghaneh, P., Halloran, C., & Mann, K. (2019). A multicentre investigation into the management and outcome of patients treated for Pyogenic Liver Abscess. In BRITISH JOURNAL OF SURGERY Vol. 106 (pp. 29). Retrieved from https://www.webofscience.com/
An Independent Patient Data Meta Analysis to compare adjuvant therapies in patients suffering with Pancreatic Cancer
Griffin, R., Psarelli, E. -E., Ghaneh, P., Neoptolemos, J., & Jackson, R. (2019). An Independent Patient Data Meta Analysis to compare adjuvant therapies in patients suffering with Pancreatic Cancer. In TRIALS Vol. 20. Retrieved from https://www.webofscience.com/
Early specialist opinion may reduce the use of percutaneous cholecystostomy for cholecystitis - a collaborative regional study
Mann, K., Dickerson, L., Fretwell, V., Sheel, A., Ghaneh, P., & Halloran, C. (2019). Early specialist opinion may reduce the use of percutaneous cholecystostomy for cholecystitis - a collaborative regional study. In BRITISH JOURNAL OF SURGERY Vol. 106 (pp. 10-11). Retrieved from https://www.webofscience.com/
Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated with the Stratified Risk of Cancer.
Sheel, A. R. G., Harrison, S., Sarantitis, I., Nicholson, J. A., Hanna, T., Grocock, C., . . . Greenhalf, W. (2019). Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated with the Stratified Risk of Cancer.. The American Journal of Gastroenterology (Elsevier), 114(1), 155-164. doi:10.1038/s41395-018-0395-y
Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma (PDAC) in the ESPAC-4 Randomized Adjuvant Chemotherapy Trial
Neoptolemos, J. P., Jones, R. P., Psarelli, E. E., Jackson, R., Ghaneh, P., Halloran, C. M., . . . Buechler, M. W. (2019). Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma (PDAC) in the ESPAC-4 Randomized Adjuvant Chemotherapy Trial. In PANCREAS Vol. 48 (pp. 1497-1498). Retrieved from https://www.webofscience.com/
Pre-operative anaemia increases length of stay and transfusion requirements in patients undergoing major pancreatic resection
Dickerson, L., Downey, R., Cawley, A., Dunne, D., Szatmary, P., Ghaneh, P., . . . Baron, R. (2019). Pre-operative anaemia increases length of stay and transfusion requirements in patients undergoing major pancreatic resection. In BRITISH JOURNAL OF SURGERY Vol. 106 (pp. 17-18). Retrieved from https://www.webofscience.com/
The evolution and development of an acute pancreatitis tertiary centre
Taylor, L., Saunders, R., McCready, R., Hughes, F., Raraty, M., Baron, R., . . . Halloran, C. (2019). The evolution and development of an acute pancreatitis tertiary centre. In BRITISH JOURNAL OF SURGERY Vol. 106 (pp. 18). Retrieved from https://www.webofscience.com/
hENT1 RNA and Protein in Combination May Act as Predictive Biomarkers for Survival for Patients Treated With Adjuvant Gemcitabine in Pancreatic Cancer
Hale, J., Evans, A., Aughton, K., Elander, N. O., Ghaneh, P., Neoptolemos, J. P., . . . Greenhalf, W. (2019). hENT1 RNA and Protein in Combination May Act as Predictive Biomarkers for Survival for Patients Treated With Adjuvant Gemcitabine in Pancreatic Cancer. In PANCREAS Vol. 48 (pp. 1436-1437). Retrieved from https://www.webofscience.com/
2018
Role of Radiological Imaging in the Diagnosis and Characterization of Pancreatic Cystic Lesions: A Systematic Review
Mohamed, E., Jackson, R., Halloran, C. M., & Ghaneh, P. (2018). Role of Radiological Imaging in the Diagnosis and Characterization of Pancreatic Cystic Lesions: A Systematic Review. PANCREAS, 47(9), 1055-1064. doi:10.1097/MPA.0000000000001134
The diagnostic value of Rosemont and Japanese diagnostic criteria for 'indeterminate', 'suggestive', 'possible' and 'early' chronic pancreatitis
Sheel, A. R. G., Baron, R. D., Sarantitis, I., Ramesh, J., Ghaneh, P., Raraty, M. G. T., . . . Neoptolemos, J. P. (2018). The diagnostic value of Rosemont and Japanese diagnostic criteria for 'indeterminate', 'suggestive', 'possible' and 'early' chronic pancreatitis. PANCREATOLOGY, 18(7), 774-784. doi:10.1016/j.pan.2018.08.002
Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy
Elander, N. O., Aughton, K., Ghaneh, P., Neoptolemos, J. P., Palmer, D. H., Cox, T. F., . . . Canc, E. S. G. P. (2018). Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy. British Journal of Cancer, 118, 1084-1088. doi:10.1038/s41416-018-0005-1
Adjuvant Chemotherapy in Pancreatic Cancer
Neoptolemos, J. P., Cunningham, D., Sclafani, F., & Ghaneh, P. (2018). Adjuvant Chemotherapy in Pancreatic Cancer. In Pancreatic Cancer (pp. 1039-1071). Springer New York. doi:10.1007/978-1-4939-7193-0_43
Arterial Resection in Pancreatic Cancer
Dunne, D. F. J., Kleeff, J., Yip, V. S., Halloran, C., Ghaneh, P., & Neoptolemos, J. P. (2018). Arterial Resection in Pancreatic Cancer. In Pancreatic Cancer (pp. 1089-1104). Springer New York. doi:10.1007/978-1-4939-7193-0_72
Laparoscopic Staging in Patients with Newly Diagnosed Pancreatic Cancer
Gilbert, T., Baron, R., Ghaneh, P., & Halloran, C. (2018). Laparoscopic Staging in Patients with Newly Diagnosed Pancreatic Cancer. In Pancreatic Cancer (pp. 753-769). Springer New York. doi:10.1007/978-1-4939-7193-0_80
European evidence-based guidelines on pancreatic cystic neoplasms
Del Chiaro, M., Besselink, M. G., Scholten, L., Bruno, M. J., Cahen, D. L., Gress, T. M., . . . Tum, E. S. G. C. (2018). European evidence-based guidelines on pancreatic cystic neoplasms. GUT, 67(5), 789-804. doi:10.1136/gutjnl-2018-316027
Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predict survival in pancreatic cancer.
Elander, N. O., Aughton, K., Ghaneh, P., Neoptolemos, J. P., Palmer, D. H., Cox, T. F., . . . Greenhalf, W. (2018). Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predict survival in pancreatic cancer.. British Journal of Cancer, 118(7), 947-954. doi:10.1038/s41416-018-0004-2
Cytoplasmic HuR Status Predicts Disease-Free Survival in Resected Pancreatic Cancer: A Post-Hoc Analysis from the International Multi-Institutional Phase III ESPAC-3 Clinical Trial
Halloran, C. M. (2018). Cytoplasmic HuR Status Predicts Disease-Free Survival in Resected Pancreatic Cancer: A Post-Hoc Analysis from the International Multi-Institutional Phase III ESPAC-3 Clinical Trial. Annals of Surgery, 267(2), 364-369. doi:10.1097/SLA.0000000000002088
PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality <SUP>18</SUP>fluorine-2-fluoro-2-deoxy-D-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer
Ghaneh, P., Hanson, R., Titman, A., Lancaster, G., Plumpton, C., Lloyd-Williams, H., . . . Neoptolemos, J. P. (2018). PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality <SUP>18</SUP>fluorine-2-fluoro-2-deoxy-D-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer. HEALTH TECHNOLOGY ASSESSMENT, 22(7), 1-+. doi:10.3310/hta22070
Pancreatic Cancer and FOLFIRINOX: Should We Resect All Responders?
Neoptolemos, J. P., Halloran, C. M., Ghaneh, P., & Kleeff, J. (2018). Pancreatic Cancer and FOLFIRINOX: Should We Resect All Responders?. Ann Surg, 267(2), e35-e36. doi:10.1097/SLA.0000000000002026
2017
Nrf2 in Pancreatic Cancer Chemotherapy Response and the Use of Brusatol as a Chemotherapeutic Agent
Williams, D., Gana, T., Sivapalan, L., Butler, O., Jackson, R., Perez-Mancera, P., . . . Costello, E. (2017). Nrf2 in Pancreatic Cancer Chemotherapy Response and the Use of Brusatol as a Chemotherapeutic Agent. In PANCREAS Vol. 46 (pp. 1443). Retrieved from http://gateway.webofknowledge.com/
The Prevalence of Diabetes Mellitus is Significantly Higher for Patients Undergoing Surgery for Pancreatic Ductal Adenocarcinoma Compared to Surgery for Other Pancreatic Pathologies
Rao, R. G., Costello, E., Halloran, C. M., Oldfield, L., Greenhalf, W., Ghaneh, P., . . . Mann, K. (2017). The Prevalence of Diabetes Mellitus is Significantly Higher for Patients Undergoing Surgery for Pancreatic Ductal Adenocarcinoma Compared to Surgery for Other Pancreatic Pathologies. In PANCREAS Vol. 46 (pp. 1403-1404). Retrieved from https://www.webofscience.com/
COST-EFFECTIVENESS OF PET/CT IN PRE-OPERATIVE STAGING OF PANCREATIC CANCER: AN ECONOMIC EVALUATION OF THE PET-PANC COHORT STUDY
Plumpton, C. O., Ghaneh, P., Lloyd-Williams, H., Yeo, S. T., & Edwards, R. T. (2017). COST-EFFECTIVENESS OF PET/CT IN PRE-OPERATIVE STAGING OF PANCREATIC CANCER: AN ECONOMIC EVALUATION OF THE PET-PANC COHORT STUDY. In VALUE IN HEALTH Vol. 20 (pp. A589). doi:10.1016/j.jval.2017.08.1078
GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer
Martinelli, P., Pau, E. C. D. S., Cox, T., Sainz, B., Dusetti, N., Greenhalf, W., . . . Real, F. X. (2017). GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer. Gut, 66(9), 1665-1676. doi:10.1136/gutjnl-2015-311256
Sample size re-estimation in paired comparative diagnostic accuracy studies with a binary response
McCray, G. P. J., Titman, A. C., Ghaneh, P., & Lancaster, G. A. (2017). Sample size re-estimation in paired comparative diagnostic accuracy studies with a binary response. BMC MEDICAL RESEARCH METHODOLOGY, 17. doi:10.1186/s12874-017-0386-5
USAGE OF TRANSMURAL METAL STENTS FOR ENDOSCOPIC ULTRASOUND GUIDED DRAINAGE OF PSEUDOCYSTS MAY LEAD TO LOWER REINTERVENTION RATES
Ramesh, J., Saunders, R., Evans, J., Ghaneh, P., Raraty, M., Yip, V., . . . Halloran, C. (2017). USAGE OF TRANSMURAL METAL STENTS FOR ENDOSCOPIC ULTRASOUND GUIDED DRAINAGE OF PSEUDOCYSTS MAY LEAD TO LOWER REINTERVENTION RATES. In GUT Vol. 66 (pp. A276). doi:10.1136/gutjnl-2017-314472.538
Biomarker prediction of efficacy to vandetanib plus gemcitabine in a phase II double blind multicenter randomized placebo controlled trial in locally advanced or metastatic pancreatic carcinoma.
Neoptolemos, J. P., Palmer, D., Greenhalf, W., Ghaneh, P., Jackson, R., Evans, A., . . . Middleton, G. W. (2017). Biomarker prediction of efficacy to vandetanib plus gemcitabine in a phase II double blind multicenter randomized placebo controlled trial in locally advanced or metastatic pancreatic carcinoma.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 35. doi:10.1200/JCO.2017.35.15_suppl.4104
Beyond ESPAC-4: better surgery and systemic therapy
Psarelli, E. E., Jackson, R., Neoptolemos, J. P., Palmer, D. H., Ghaneh, P., Halloran, C. M., & Buechler, M. W. (2017). Beyond ESPAC-4: better surgery and systemic therapy. LANCET, 389(10078), 1517-1518. doi:10.1016/S0140-6736(17)30947-9
Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial
Middleton, G., Palmer, D. H., Greenhalf, W., Ghaneh, P., Jackson, R., Cox, T., . . . Neoptolemos, J. P. (2017). Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial. The Lancet Oncology, 18(4), 486-499. doi:10.1016/S1470-2045(17)30084-0
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.
Neoptolemos, J. P., Palmer, D. H., Ghaneh, P., Psarelli, E. E., Valle, J. W., Halloran, C. M., . . . Büchler, M. W. (2017). Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.. Lancet (London, England), 389(10073), 1011-1024. doi:10.1016/s0140-6736(16)32409-6
Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcinoma undergoing adjuvant gemcitabine-based chemotherapy
Bird, N. T. E., Elmasry, M., Jones, R., Psarelli, E., Dodd, J., Malik, H., . . . Palmer, D. (2017). Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcinoma undergoing adjuvant gemcitabine-based chemotherapy. BRITISH JOURNAL OF SURGERY, 104(4), 328-336. doi:10.1002/bjs.10482
Internal pilot sample size re-estimation in paired comparative diagnostic accuracy trials with a binary response
McCray, G., Titman, A., Ghaneh, P., & Lancaster, G. (2017). Internal pilot sample size re-estimation in paired comparative diagnostic accuracy trials with a binary response. In TRIALS Vol. 18. Retrieved from https://www.webofscience.com/
Pancreatic necrosis: patterns of microbiology culture results and antibiotics sensitivity
Mohamed, E., Wai, M., & Ghaneh, P. (2017). Pancreatic necrosis: patterns of microbiology culture results and antibiotics sensitivity. In BRITISH JOURNAL OF SURGERY Vol. 104 (pp. 32). Retrieved from https://www.webofscience.com/
Small pancreatic ductal adenocarcinoma: a true clinical entity or an invalid diagnostic myth
Mohamed, E., Dodd, J., & Ghaneh, P. (2017). Small pancreatic ductal adenocarcinoma: a true clinical entity or an invalid diagnostic myth. In BRITISH JOURNAL OF SURGERY Vol. 104 (pp. 12-13). Retrieved from https://www.webofscience.com/
Treatment of walled off pancreatic necrosis by indirect trannsluminal irrigation endoscopic necrosectomy
Ramesh, J., Saunders, R., Evans, J., Smart, H., McCready, R., Hughes, F., . . . Halloran, C. (2017). Treatment of walled off pancreatic necrosis by indirect trannsluminal irrigation endoscopic necrosectomy. In BRITISH JOURNAL OF SURGERY Vol. 104 (pp. 18). Retrieved from https://www.webofscience.com/
Usage of transmural metal stents for endoscopic ultrasound guided drainage of pseudocysts may lead to lower reintervention rates
Ramesh, J., Saunders, R., Evans, J., Ghaneh, P., Raraty, M., Yip, V., . . . Halloran, C. (2017). Usage of transmural metal stents for endoscopic ultrasound guided drainage of pseudocysts may lead to lower reintervention rates. In BRITISH JOURNAL OF SURGERY Vol. 104 (pp. 27). Retrieved from https://www.webofscience.com/
2016
ESPAC-4: A Multicenter, International, Randomized Controlled Phase III Trial of Adjuvant Combination Chemotherapy of Gemcitabine (GEM) and Capecitabine (CAP), Versus Monotherapy Gemcitabine in Patients With Resected Pancreatic Ductal Adenocarcinoma
Neoptolemos, J. P., Palmer, D., Ghaneh, P., Valle, J., Cunningham, D., Wadsley, J., . . . Buechler, M. W. (2016). ESPAC-4: A Multicenter, International, Randomized Controlled Phase III Trial of Adjuvant Combination Chemotherapy of Gemcitabine (GEM) and Capecitabine (CAP), Versus Monotherapy Gemcitabine in Patients With Resected Pancreatic Ductal Adenocarcinoma. In Pancreas Vol. 45 (pp. 1529). Boston: Wolters Kluwer Health. Retrieved from https://journals.lww.com/
Misdiagnosis of Chronic Pancreatitis (CP) in a UK Regional Pancreas Center
Sheel, A. R. G., Halloran, C., Ghaneh, P., Baron, R. D., Raraty, M., Kleeff, J., . . . Neoptolemos, J. P. (2016). Misdiagnosis of Chronic Pancreatitis (CP) in a UK Regional Pancreas Center. In Pancreas Vol. 45 (pp. 1538). Boston: Wolters Kluwer Health. Retrieved from https://journals.lww.com/
Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenocarcinoma.
Connor, A. A., Denroche, R. E., Jang, G. H., Timms, L., Kalimuthu, S. N., Selander, I., . . . Gallinger, S. (2016). Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenocarcinoma.. JAMA oncology, 3(6), 774-783. doi:10.1001/jamaoncol.2016.3916
Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients
Rizzato, C., Campa, D., Talar-Wojnarowska, R., Halloran, C., Kupcinskas, J., Butturini, G., . . . Canzian, F. (2016). Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients. Carcinogenesis, 37(10), 957-964. doi:10.1093/carcin/bgw080
Objective assessment of trainee operative experience in a tertiary hepatobiliary unit
Joshi, H. M., Alabraba, E., Tufo, A., Zone, A., Ghaneh, P., Fenwick, S. W., . . . Malik, H. Z. (2016). Objective assessment of trainee operative experience in a tertiary hepatobiliary unit. EJSO, 42(10), 1548-1551. doi:10.1016/j.ejso.2016.07.139
The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer
Kleeff, J., Costello, E., Jackson, R., Halloran, C., Greenhalf, W., Ghaneh, P., . . . Neoptolemos, J. P. (2016). The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer. BRITISH JOURNAL OF CANCER, 115(7), 887-894. doi:10.1038/bjc.2016.277
PET-PANC: Multi-centre prospective diagnostic accuracy and clinical value trial of FDG PET/CT in the diagnosis and management of suspected pancreatic cancer
Ghaneh, P., Wong, W. L., Titman, A., Plumpton, C., Vinjamuri, S., Johnson, C., . . . Neoptolemos, J. P. (2016). PET-PANC: Multi-centre prospective diagnostic accuracy and clinical value trial of FDG PET/CT in the diagnosis and management of suspected pancreatic cancer. In JOURNAL OF CLINICAL ONCOLOGY Vol. 34. doi:10.1200/JCO.2016.34.15_suppl.4008
PET-PANC: Multi-centre prospective diagnostic accuracy and clinical value trial of FDG PET/CT in the diagnosis and management of suspected pancreatic cancer.
Ghaneh, P., Wong, W. L., Titman, A., Plumpton, C., Vinjamuri, S., Johnson, C., . . . Neoptolemos, J. P. (2016). PET-PANC: Multi-centre prospective diagnostic accuracy and clinical value trial of FDG PET/CT in the diagnosis and management of suspected pancreatic cancer.. In Journal of Clinical Oncology Vol. Vol 34. Chicago: American Society of Clinical Oncology.
Pancreatic cancer
Kleeff, J., Korc, M., Apte, M., La Vecchia, C., Johnson, C. D., Biankin, A. V., . . . Neoptolemos, J. P. (2016). Pancreatic cancer. In Unknown Book (Vol. 2). doi:10.1038/nrdp.2016.22
A Personalized Approach to Adjuvant Therapy: Cytoplasmic HuR Status Predicts Disease Free Survival After Resection for Pancreatic Ductal Adenocarcinoma
Tatarian, T., Grigoli, A., Leiby, B. E., Jimbo, M., Dabbish, N., Jiang, W., . . . Brody, J. R. (2016). A Personalized Approach to Adjuvant Therapy: Cytoplasmic HuR Status Predicts Disease Free Survival After Resection for Pancreatic Ductal Adenocarcinoma. In GASTROENTEROLOGY Vol. 150 (pp. S1211). doi:10.1016/S0016-5085(16)34095-1
Management and Outcome of 64 Patients with Pancreatic Serous Cystic Neoplasms
Gomatos, I. P., Halloran, C., Ghaneh, P., Raraty, M., Polydoros, F., Campbell, F., . . . Neoptolemos, J. P. (2016). Management and Outcome of 64 Patients with Pancreatic Serous Cystic Neoplasms. DIGESTIVE SURGERY, 33(3), 203-212. doi:10.1159/000442094
Preface
Khosmood, F., & Fowler, A. (2016). Preface. Proceedings of the International Conference on Game Jams, Hackathons, and Game Creation Events, GJH and GC 2016.
Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma
Middleton, G., Greenhalf, W., Costello, E., Shaw, V., Cox, T., Ghaneh, P., . . . Neoptolemos, J. P. (2016). Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma. British Journal of Cancer, 114, 510-518. doi:10.1038/bjc.2015.468
PANasta Trial; Cattell Warren versus Blumgart techniques of panreatico-jejunostomy following pancreato-duodenectomy: Study protocol for a randomized controlled trial
Halloran, C. M., Platt, K., Gerard, A., Polydoros, F., O'Reilly, D. A., Gomez, D., . . . Ghaneh, P. (2016). PANasta Trial; Cattell Warren versus Blumgart techniques of panreatico-jejunostomy following pancreato-duodenectomy: Study protocol for a randomized controlled trial. TRIALS, 17. doi:10.1186/s13063-015-1144-9
Changes in the Expression of RRM Subunits Induce Gemcitabine Resistance in a Growth Dependent Manner
Mann, K. S., Brumskill, S., Ghaneh, P., & Greenhalf, W. (2016). Changes in the Expression of RRM Subunits Induce Gemcitabine Resistance in a Growth Dependent Manner. PANCREAS, 45(10), 1523. Retrieved from https://www.webofscience.com/
ESPAC-4: A multicenter, international, open-label randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (GEM) and capecitabine (CAP) versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma.
Neoptolemos, J. P., Palmer, D., Ghaneh, P., Valle, J. W., Cunningham, D., Wadsley, J., . . . Buchler, M. W. (2016). ESPAC-4: A multicenter, international, open-label randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (GEM) and capecitabine (CAP) versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 34. Retrieved from https://www.webofscience.com/
Outcomes From Minimal Access Retroperitoneal and Open Pancreatic Necrosectomy in 394 Patients With Necrotizing Pancreatitis
Gomatis, I., Halloran, C. M., Ghaneh, P., Raraty, M., Polydoros, F., Evans, J. C., . . . Neoptolemos, J. P. (2016). Outcomes From Minimal Access Retroperitoneal and Open Pancreatic Necrosectomy in 394 Patients With Necrotizing Pancreatitis. Annals of Surgery, 263(5), 992-1001. doi:10.1097/SLA.0000000000001407
Pancreatic and ampullary cancer
Mann, K., Gilbert, T., Oldfield, F., & Ghaneh, P. (2016). Pancreatic and ampullary cancer. In Surgical Oncology: Theory and Multidisciplinary Practice, Second Edition (pp. 403-427).
2015
What Is the Best Way to Identify Malignant Transformation Within Pancreatic IPMN: A Systematic Review and Meta-Analyses
Sultana, A., Jackson, R., Gilbert, T., Bostock, E., Psarelli, E., Cox, T., . . . Halloran, C. (2015). What Is the Best Way to Identify MalignantTransformation Within Pancreatic IPMN: A SystematicReview and Meta-Analyses. Clinical and Translational Gastroenterology, 6(12), e130. doi:10.1038/ctg.2015.60
Actinomycin D Sensitizes Chemotherapy Resistant Suit-2 Pancreatic Cancer Cell Lines to Gemcitabine
Mann, K., Rogoyski, B., Ghaneh, P., Rubbi, C., & Greenhalf, W. (2015). Actinomycin D Sensitizes Chemotherapy Resistant Suit-2 Pancreatic Cancer Cell Lines to Gemcitabine. Pancreas, 44(8), 1395-1396. Retrieved from https://journals.lww.com/
Evidence of adjuvant chemotherapy of ductal pancreatic cancer
Sultana, A., Halloran, C., Palmer, D., Ghaneh, P., Cox, T., & Neoptolemos, J. P. (2015). Evidence of adjuvant chemotherapy of ductal pancreatic cancer. In PANCREATIC CANCER, CYSTIC NEOPLASMS, AND ENDOCRINE TUMORS: DIAGNOSIS AND MANAGEMENT (pp. 94-102). Retrieved from https://www.webofscience.com/
Biomarkers for early diagnosis of pancreatic cancer
Jenkinson, C., Earl, J., Ghaneh, P., Halloran, C., Carrato, A., Greenhalf, B., . . . Costello-Goldring, E. (2015). Biomarkers for early diagnosis of pancreatic cancer. Expert Review of Gastroenterology & Hepatology, 9(03), 305-315. doi:10.1586/17474124.2015.965145
A Single p53 Mutation May Predict Survival in Intraductal Papillary Mucinous Neoplasms of the Pancreas
Nicholson, J., Howes, N., Harrison, S., Hanna, T., Yan, L., Lane, B., . . . Greenhalf, W. (2015). A Single p53 Mutation May Predict Survival in Intraductal Papillary Mucinous Neoplasms of the Pancreas. PANCREAS, 44(8), 1402. Retrieved from https://www.webofscience.com/
Adjuvant Therapy in Pancreatic Cancer
Oldfield, F., Ghaneh, P., Jackson, R., & Halloran, C. (n.d.). Adjuvant Therapy in Pancreatic Cancer. International Journal of Digestive Diseases, 01(01). doi:10.4172/2472-1891.100003
Cytidine Deaminase (CDA) Transcript Analysis Complements hENT1 Protein Staining in Predicting Gemcitabine Response in the ESPAC-3 Pancreatic Cancer Cohort
Elander, N., Aughton, K., Ghaneh, P., Neoptolemos, J. P., Costello, E., Palmer, D., . . . Greenhalf, W. (2015). Cytidine Deaminase (CDA) Transcript Analysis Complements hENT1 Protein Staining in Predicting Gemcitabine Response in the ESPAC-3 Pancreatic Cancer Cohort. PANCREAS, 44(8), 1371. Retrieved from https://www.webofscience.com/
Incidence of post-ERCP pancreatitis from direct pancreatic juice collection in hereditary pancreatitis and familial pancreatic cancer before and after the introduction of prophylactic pancreatic stents and rectal diclofenac.
Nicholson, J., Greenhalf, B., Jackson, R., Cox, T., Butler, J., Hanna, T., . . . Neoptolemos, J. (2015). Incidence of post-ERCP pancreatitis from direct pancreatic juice collection in hereditary pancreatitis and familial pancreatic cancer before and after the introduction of prophylactic pancreatic stents and rectal diclofenac.. Pancreas, 44(02), 260-265. doi:10.1097/MPA.0000000000000246
2014
Adjuvant therapy in pancreatic cancer
Jones, O. P., Melling, J. D., & Ghaneh, P. (2014). Adjuvant therapy in pancreatic cancer. WORLD JOURNAL OF GASTROENTEROLOGY, 20(40), 14733-14746. doi:10.3748/wjg.v20.i40.14733
Risk stratification, management and outcomes in emergency general surgical patients in the UK
Johnstone, M., Pennick, M., Gossedge, G., Oshin, O., Sutton, P., Dunne, D., . . . Vimalachandran, D. (2014). Risk stratification, management and outcomes in emergency general surgical patients in the UK. EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY, 40(5), 617-624. doi:10.1007/s00068-014-0399-2
Chemotherapy, radiotherapy, chemoradiotherapy and combination therapy in localised and locally advanced pancreatic cancer
Sultana, A., Jackson, R. J., Cox, T., Palmer, D., Neoptolemos, J., & Ghaneh, P. (n.d.). Chemotherapy, radiotherapy, chemoradiotherapy and combination therapy in localised and locally advanced pancreatic cancer. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd011044
Prognostic markers in acute pancreatitis
Gomatos, I. P., Xiaodong, X., Ghaneh, P., Halloran, C., Raraty, M., Lane, B., . . . Neoptolemos, J. P. (2014). Prognostic markers in acute pancreatitis. Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare, 14(3), 333-346. doi:10.1586/14737159.2014.897608
Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study.
Valle, J., Palmer, D., Jackson, R., Cox, T., Neoptolemos, J. P., Ghaneh, P., . . . Büchler, M. W. (2014). Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study.. Journal of Clinical Oncology, 32(6), 504-512. doi:10.1200/JCO.2013.50.7657
Adjuvant chemotherapy for rectal cancer
Thornton, M., & Rooney, P. S. (2014). Adjuvant chemotherapy for rectal cancer. In Unknown Book (Vol. 15, pp. e196). Elsevier BV. doi:10.1016/s1470-2045(14)70130-5
Combination Therapy With Gemcitabine and a Novel Plk1 Inhibitor Causes Caspase-Independent Cell Death in Pancreatic Cancer Cells
Jones, O. P., Greenhalf, W., Halloran, C., Neoptolemos, J. P., & Ghaneh, P. (2014). Combination Therapy With Gemcitabine and a Novel Plk1 Inhibitor Causes Caspase-Independent Cell Death in Pancreatic Cancer Cells. PANCREAS, 43(8), 1372. Retrieved from https://www.webofscience.com/
Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)
Bonnetain, F., Bonsing, B., Conroy, T., Dousseau, A., Glimelius, B., Haustermans, K., . . . Collette, L. (2014). Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials). European Journal of Cancer, 50(17), 2983-2993. doi:10.1016/j.ejca.2014.07.011
Outcomes From Minimal Access Retroperitoneal and Open Pancreatic Necrosectomy in 394 Patients With Necrotizing Pancreatitis
Gomatos, I., Halloran, C., Raraty, M., Evans, J., Ghaneh, P., Smart, H., . . . Neoptolemos, J. (2014). Outcomes From Minimal Access Retroperitoneal and Open Pancreatic Necrosectomy in 394 Patients With Necrotizing Pancreatitis. PANCREAS, 43(8), 1360-1361. Retrieved from https://www.webofscience.com/
Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial.
Greenhalf, W., Ghaneh, P., Neoptolemos, J. P., Palmer, D. H., Cox, T. F., Lamb, R. F., . . . Büchler, M. W. (2014). Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial.. Journal of the National Cancer Institute, 106(1). doi:10.1093/jnci/djt347
Risk of Other Cancers in Familial Pancreatic Cancer
Hanna, T., Nicholson, J., Harrison, S., Johnstone, M., Ghaneh, P., Sutton, R., . . . Greenhalf, W. (2014). Risk of Other Cancers in Familial Pancreatic Cancer. PANCREAS, 43(8), 1363. Retrieved from https://www.webofscience.com/
Systematic review and meta-analyses of the diagnosis of Pancreatic Intraductal Papillary Mucinous Neoplasia (IPMN)
Sultana, A., Jackson, R., Ghaneh, P., Raraty, M., Sutton, R., Neoptolemos, J., & Halloran, C. (2014). Systematic review and meta-analyses of the diagnosis of Pancreatic Intraductal Papillary Mucinous Neoplasia (IPMN). In BRITISH JOURNAL OF SURGERY Vol. 101 (pp. 28). Retrieved from https://www.webofscience.com/
The Liverpool uveal melanoma liver metastases pathway: Outcome following liver resection
Gomez, D., Wetherill, C., Cheong, J., Jones, L., Marshall, E., Damato, B., . . . Fenwick, S. W. (2014). The Liverpool uveal melanoma liver metastases pathway: Outcome following liver resection. JOURNAL OF SURGICAL ONCOLOGY, 109(6), 542-547. doi:10.1002/jso.23535
Use of Citrullinated Histones and Circulating Nucleosomes in Early Prediction of Organ Failure in Acute Pancreatitis
Szatmary, P., Liu, T., Huang, W., Wang, G., Latawiec, D., Davies, K., . . . Sutton, R. (2014). Use of Citrullinated Histones and Circulating Nucleosomes in Early Prediction of Organ Failure in Acute Pancreatitis. PANCREAS, 43(8), 1413. Retrieved from https://www.webofscience.com/
2013
Hepatic activation of irinotecan predicts tumour response in patients with colorectal liver metastases treated with DEBIRI: exploratory findings from a phase II study
Jones, R. P., Sutton, P., Greensmith, R. M. D., Santoyo-Castelazo, A., Carr, D. F., Jenkins, R., . . . Kitteringham, N. R. (2013). Hepatic activation of irinotecan predicts tumour response in patients with colorectal liver metastases treated with DEBIRI: exploratory findings from a phase II study. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 72(2), 359-368. doi:10.1007/s00280-013-2199-5
MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients
Marshall, E., Romaniuk, C., Ghaneh, P., Wong, H., McKay, M., Chopra, M., . . . Damato, B. E. (2013). MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients. BRITISH JOURNAL OF OPHTHALMOLOGY, 97(2), 159-163. doi:10.1136/bjophthalmol-2012-302323
MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients
Marshall, E., Romaniuk, C., Ghaneh, P., Wong, H., McKay, M., Chopra, M., . . . Damato, B. E. (2013). MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients. British Journal of Ophthalmology, 97(2), 159-163. doi:10.1136/bjophthalmol-2012-302323
CA19-9 Is a Significant Prognostic Factor Following Pancreatoduodenectomy for Intra-Pancreatic Bile Duct Cancer (Cholangiocarcinoma)
Melling, J., Thomas, A., Sykes, P., Jones, O., Jackson, R., Whelan, P., . . . Ghaneh, P. (2013). CA19-9 Is a Significant Prognostic Factor Following Pancreatoduodenectomy for Intra-Pancreatic Bile Duct Cancer (Cholangiocarcinoma). In PANCREAS Vol. 42 (pp. 1367-1368). Retrieved from https://www.webofscience.com/
Characteristics and Outcomes of Borderline Resectable Pancreatic Cancer Compared with Resectable Disease
Thomas, A., Melling, J., Jackson, R., Whelan, P., Sykes, P., Jones, O., . . . Ghaneh, P. (2013). Characteristics and Outcomes of Borderline Resectable Pancreatic Cancer Compared with Resectable Disease. In PANCREAS Vol. 42 (pp. 1386). Retrieved from https://www.webofscience.com/
Consensus for definition of time-to-event endpoints in pancreatic
Bonnetain, F., Bonsing, B., & Ghaneh et al, P. (2013). Consensus for definition of time-to-event endpoints in pancreatic. Lancet Oncology.
Development of a Novel Next Generation Sequencing (NGS) Method for Detection of Low Concentration Sequence Variants
Yan, L., Nicholson, J. A., Bennet, L., Bullock, K., Lombard, M., Smart, H., . . . Greenhalf, W. (2013). Development of a Novel Next Generation Sequencing (NGS) Method for Detection of Low Concentration Sequence Variants. In PANCREAS Vol. 42 (pp. 1390). Retrieved from https://www.webofscience.com/
Inhibition of Pancreatitis-Associated Cell Death Using a Human Pancreatic Acinar Cell Model
Javed, M. A., Mukherjee, R., Wen, L., Huang, W., Chvanov, M., Awais, M., . . . Sutton, R. (2013). Inhibition of Pancreatitis-Associated Cell Death Using a Human Pancreatic Acinar Cell Model. In PANCREAS Vol. 42 (pp. 1356). Retrieved from https://www.webofscience.com/
Is the Association of the p.N34S SPINK1 Variant Explicable by a High Risk Haplotype Rather Than the Polymorphism?
Nicholson, J. A., Grant, J., Johnstone, M., Harrison, S., Halloran, C. M., Raraty, M. G. T., . . . Greenhalf, W. (2013). Is the Association of the p.N34S SPINK1 Variant Explicable by a High Risk Haplotype Rather Than the Polymorphism?. In PANCREAS Vol. 42 (pp. 1372). Retrieved from https://www.webofscience.com/
MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients.
Marshall, E., Romaniuk, C., Ghaneh, P., Wong, H., McKay, M., Chopra, M., . . . Damato, B. E. (2013). MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients.. Br J Ophthalmol, 97, 159-163.
Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons from the ESPAC-3 Study
Neoptolemos, J., Valle, J., Palmer, D., Jackson, R., Cox, T., Ghaneh, P., . . . Buechler, M. (2013). Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons from the ESPAC-3 Study. PANCREAS, 42(8), 1372. Retrieved from https://www.webofscience.com/
PHASE I TRIAL OF INTRA-ARTERIAL GENE DIRECTED ENZYME PRODRUG THERAPY
Ghaneh, P., Cox, T., & Neoptolemos, J. P. (2013). PHASE I TRIAL OF INTRA-ARTERIAL GENE DIRECTED ENZYME PRODRUG THERAPY. British Journal of Cancer.
Pancreatic Cancer hENT1 Expression Predicts Survival from Gemcitabine in Patients from the ESPAC-3 Trial.
Greenhalf, W., Ghaneh, P., Neoptolemos, J., Palmer, D., Cox, T., Lamb, R., . . . Büchler, M. (2013). Pancreatic Cancer hENT1 Expression Predicts Survival from Gemcitabine in Patients from the ESPAC-3 Trial.. Journal of the National Cancer Institute.
Review of PET/CT in oncology: is it cost-effective?
Hounsome, B., Edwards, R., Lloyd Williams, H., & Ghaneh, P. (2013). Review of PET/CT in oncology: is it cost-effective?. Journal of Nuclear Medicine.
TRO40303 Reduces Mitochondrial Injury and Ameliorates Experimental AP
Javed, M. A., Wen, L., Awais, M., Chvanov, M., Ghaneh, P., Halloran, C., . . . Sutton, R. (2013). TRO40303 Reduces Mitochondrial Injury and Ameliorates Experimental AP. In PANCREAS Vol. 42 (pp. 1356). Retrieved from https://www.webofscience.com/
Tumour size and differentiation predict survival after liver resection for hepatocellular carcinoma arising from non-cirrhotic and non-fibrotic liver: A case-controlled study
Yip, V. S., Gomez, D., Tan, C. Y., Staettner, S., Terlizzo, M., Fenwick, S., . . . Poston, G. (2013). Tumour size and differentiation predict survival after liver resection for hepatocellular carcinoma arising from non-cirrhotic and non-fibrotic liver: A case-controlled study. In INTERNATIONAL JOURNAL OF SURGERY Vol. 11 (pp. 1078-1082). doi:10.1016/j.ijsu.2013.10.001
2012
The Value of Source Data Verification in a Cancer Clinical Trial
Smith, C. T., Stocken, D. D., Dunn, J., Cox, T., Ghaneh, P., Cunningham, D., & Neoptolemos, J. P. (2012). The Value of Source Data Verification in a Cancer Clinical Trial. PLOS ONE, 7(12). doi:10.1371/journal.pone.0051623
Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma The ESPAC-3 Periampullary Cancer Randomized Trial
Neoptolemos, J. P., Moore, M. J., Cox, T. F., Valle, J. W., Palmer, D. H., McDonald, A. C., . . . Buechler, M. W. (2012). Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma The ESPAC-3 Periampullary Cancer Randomized Trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 308(2), 147-156. doi:10.1001/jama.2012.7352
Cholecystectomy-related bile duct and vasculobiliary injuries.
Sarno, G., Al-Sarira, A. A., Ghaneh, P., Fenwick, S. W., Malik, H. Z., & Poston, G. J. (2012). Cholecystectomy-related bile duct and vasculobiliary injuries.. The British journal of surgery, 99(8), 1129-1136. doi:10.1002/bjs.8806
Chemotherapy and radiotherapy for pancreatic and periampullary cancer
Halloran, C. M., Ghaneh, P., & Neoptolemos, J. P. (2012). Chemotherapy and radiotherapy for pancreatic and periampullary cancer. In Blumgart's Surgery of the Liver, Pancreas and Biliary Tract (pp. 972-978.e2). Elsevier. doi:10.1016/b978-1-4377-1454-8.00063-1
Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases
Jones, R. P., Jackson, R., Dunne, D. F. J., Malik, H. Z., Fenwick, S. W., Poston, G. J., & Ghaneh, P. (2012). Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases. BRITISH JOURNAL OF SURGERY, 99(4), 477-486. doi:10.1002/bjs.8667
Microwave ablation of ex vivo human liver and colorectal liver metastases with a novel 14.5 GHz generator
Jones, R. P., Kitteringham, N. R., Terlizzo, M., Hancock, C., Dunne, D., Fenwick, S. W., . . . Malik, H. Z. (2012). Microwave ablation of ex vivo human liver and colorectal liver metastases with a novel 14.5 GHz generator. INTERNATIONAL JOURNAL OF HYPERTHERMIA, 28(1), 43-54. doi:10.3109/02656736.2011.610428
Adjuvant therapy for pancreatic cancer.
Sultana, A., Cox, T., Ghaneh, P., & Neoptolemos, J. P. (2012). Adjuvant therapy for pancreatic cancer.. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 196, 65-88. doi:10.1007/978-3-642-31629-6_5
Cholecystectomy-related bile duct and vasculobiliary injuries
Sarno, G., Al-Sarira, A. A., Ghaneh, P., Fenwick, S. W., Malik, H. Z., & Poston, G. J. (2012). Cholecystectomy-related bile duct and vasculobiliary injuries. British Journal of Surgery, 99, 1129-1136.
2011
Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer.
Smith, R. A., Tang, J., Tudur-Smith, C., Neoptolemos, J. P., & Ghaneh, P. (2011). Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer.. British journal of cancer, 104(9), 1440-1451. doi:10.1038/bjc.2011.110
Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer
Smith, R. A., Tang, J., Tudur-Smith, C., Neoptolemos, J. P., & Ghaneh, P. (2011). Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer. British Journal of cancer, 104, 1140-1151.
Partial Pancreatic Resection for Pancreatic Malignancy Is Associated with Sustained Pancreatic Exocrine Failure and Reduced Quality of Life: A Prospective Study
Halloran, C. M., Cox, T. F., Chauhan, S., Raraty, M. G. T., Sutton, R., Neoptolemos, J. P., & Ghaneh, P. (2011). Partial Pancreatic Resection for Pancreatic Malignancy Is Associated with Sustained Pancreatic Exocrine Failure and Reduced Quality of Life: A Prospective Study. PANCREATOLOGY, 11(6), 535-545. doi:10.1159/000333308
Partial pancreatic resection for pancreatic malignancy is associated with sustained pancreatic exocrine failure and reduced quality of life: a prospective study
Halloran, C. M., Cox, T. F., Chauhan, S., Raraty, M. G., Sutton, R., Neoptolemos, J. P., & Ghaneh, P. (2011). Partial pancreatic resection for pancreatic malignancy is associated with sustained pancreatic exocrine failure and reduced quality of life: a prospective study. Pancreatology, 11(6), 535-545.
2010
Adjuvant therapy in pancreatic cancer.
Thomas, A., Dajani, K., Neoptolemos, J. P., & Ghaneh, P. (2010). Adjuvant therapy in pancreatic cancer.. Digestive diseases (Basel, Switzerland), 28(4-5), 684-692. doi:10.1159/000320099
Minimal Access Retroperitoneal Pancreatic Necrosectomy <i>Improvement in Morbidity and Mortality With a Less Invasive Approach</i>
Raraty, M. G. T., Halloran, C. M., Dodd, S., Ghaneh, P., Connor, S., Evans, J., . . . Neoptolemos, J. P. (2010). Minimal Access Retroperitoneal Pancreatic Necrosectomy <i>Improvement in Morbidity and Mortality With a Less Invasive Approach</i>. ANNALS OF SURGERY, 251(5), 787-793. doi:10.1097/SLA.0b013e3181d96c53
Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer.
Dive, C., Smith, R. A., Garner, E., Ward, T., George-Smith, S. S., Campbell, F., . . . Neoptolemos, J. P. (2010). Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer.. British journal of cancer, 102(3), 577-582. doi:10.1038/sj.bjc.6605494
A randomized controlled trial of adjuvant chemotherapy using 5-fluorouracil with folinic acid versus gemcitabine and in patients with resectable pancreatic cancer JAMA
Neoptolemos, J. P., Stocken, D. D., Bassi, C., Ghaneh, P., Cunningham, D., Goldstein, D., . . . European Study Group for Pancreatic Cancer.. (2010). A randomized controlled trial of adjuvant chemotherapy using 5-fluorouracil with folinic acid versus gemcitabine and in patients with resectable pancreatic cancer JAMA. Journal of the American Medical Association, 304, 1073-1081.
Drainage and bypass procedures for palliation of malignant diseases of the upper gastrointestinal tract
Huggett, M. T., Ghaneh, P., & Pereira, S. P. (2010). Drainage and bypass procedures for palliation of malignant diseases of the upper gastrointestinal tract. Clinical Oncology, 22, 755-763.
Minimal access retroperitoneal pancreatic necrosectomy: improvement in morbidity and mortality with a less invasive approach
Raraty, M. G., Halloran, C. M., Dodd, S., Ghaneh, P., Connor, S., Evans, J., . . . Neoptolemos, J. P. (2010). Minimal access retroperitoneal pancreatic necrosectomy: improvement in morbidity and mortality with a less invasive approach. Annals of Surgery, 251, 787-793.
2009
The prognostic significance of the preoperative full blood count after resection of colorectal liver metastases.
Dajani, K., O'Reilly, D. A., Carino, N. D. L., Ghaneh, P., Poston, G., & Wu, A. (2009). The prognostic significance of the preoperative full blood count after resection of colorectal liver metastases.. HPB surgery : a world journal of hepatic, pancreatic and biliary surgery, 2009, 425065. doi:10.1155/2009/425065
Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin
Campbell, F., Smith, R. A., Whelan, P., Sutton, R., Raraty, M., Neoptolemos, J. P., & Ghaneh, P. (2009). Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin. HISTOPATHOLOGY, 55(3), 277-283. doi:10.1111/j.1365-2559.2009.03376.x
Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma
Smith, R. A., Bosonnet, L., Raraty, M., Sutton, R., Neoptolemos, J. P., Campbell, F., & Ghaneh, P. (2009). Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. AMERICAN JOURNAL OF SURGERY, 197(4), 466-472. doi:10.1016/j.amjsurg.2007.12.057
Randomised Phase I/II trial assessing the safety and efficacy of radiolabelled anti-carcinoembryonic antigen I<SUP>131</SUP> KAb201 antibodies given intra-arterially or intravenously in patients with unresectable pancreatic adenocarcinoma
Sultana, A., Shore, S., Raraty, M. G. T., Vinjamuri, S., Evans, J. E., Smith, C. T., . . . Ghaneh, P. (2009). Randomised Phase I/II trial assessing the safety and efficacy of radiolabelled anti-carcinoembryonic antigen I<SUP>131</SUP> KAb201 antibodies given intra-arterially or intravenously in patients with unresectable pancreatic adenocarcinoma. BMC CANCER, 9. doi:10.1186/1471-2407-9-66
Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials.
Neoptolemos, J. P., Stocken, D. D., Tudur Smith, C., Bassi, C., Ghaneh, P., Owen, E., . . . Büchler, M. W. (2009). Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials.. British journal of cancer, 100(2), 246-250. doi:10.1038/sj.bjc.6604838
Factors involved in carcinogenesis and prevention in hepatobiliary cancer
Ghaneh, P., Greenhalf, W., & Neoptolemos, J. P. (2009). Factors involved in carcinogenesis and prevention in hepatobiliary cancer. In Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach (pp. 421-432).
Confounding Effect of Obstructive Jaundice in the Interpretation of Proteomic Plasma Profiling Data for Pancreatic Cancer
Yan, L., Tonack, S., Smith, R., Dodd, S., Jenkins, R. E., Kitteringham, N., . . . Costello, E. (2009). Confounding Effect of Obstructive Jaundice in the Interpretation of Proteomic Plasma Profiling Data for Pancreatic Cancer. JOURNAL OF PROTEOME RESEARCH, 8(1), 142-148. doi:10.1021/pr800451h
'Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma'
Smith, R. A., Bosonnet, L., Raraty, M., Sutton, R., Neoptolemos, J. P., Campbell, F., & Ghaneh, P. (2009). 'Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma'. American Journal of Surgery, 167, 466-472.
A preoperative prognostic score for resected pancreatic and periampullary neuroendocrine tumours.
Sakka, N., Smith, R. A., Whelan, P., Ghaneh, P., Sutton, R., Raraty, M., . . . Neoptolemos, J. P. (2009). A preoperative prognostic score for resected pancreatic and periampullary neuroendocrine tumours.. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 9(5), 670-676. doi:10.1159/000181179
A preoperative prognostic score for resected pancreatic and periampullary neuroendocrine tumours.
Sakka, N., Smith, R., Whelan, P., Ghaneh, P., Sutton, R., Raraty, M., . . . Neoptolemos, J. P. (2009). A preoperative prognostic score for resected pancreatic and periampullary neuroendocrine tumours.. Pancreatology, 9, 670-676.
Longitudinal Quality of Life Data can provide Insights on the Impact of Adjuvant Treatment for Pancreatic Cancer - Subset Analysis of the ESPAC-1 Data
Carter, R., Stocken, D. D., Bramhall, S., Olah, A., Kelemen, D., Bassi, C., . . . Neoptolemos, J. P. (2009). Longitudinal Quality of Life Data can provide Insights on the Impact of Adjuvant Treatment for Pancreatic Cancer - Subset Analysis of the ESPAC-1 Data. International Journal of Cancer, 124, 2960-2965.
Perioperative use of the LiMON method of indocyanine green elimination measurement for the prediction and early detection of post-hepatectomy liver failure
de Liguori Carino, N., O'Reilly, D. A., Dajani, K., Ghaneh, P., Poston, G. J., & Wu, A. V. (2009). Perioperative use of the LiMON method of indocyanine green elimination measurement for the prediction and early detection of post-hepatectomy liver failure. European Journal of Surgical Oncology, 35, 957-962.
Randomised Phase I/II trial assessing the safety and efficacy of radio labelled anti-carcinoembryonic antigen antibodies given intra-arterially or intravenously in patients with unresectable pancreatic adenocarcinoma
Sultana, A., Shore, S., Vinjamuri, S., Evans, J. C., Tudur Smith, C., Chauhan, S., . . . Ghaneh, P. (2009). Randomised Phase I/II trial assessing the safety and efficacy of radio labelled anti-carcinoembryonic antigen antibodies given intra-arterially or intravenously in patients with unresectable pancreatic adenocarcinoma. BMC cancer, 9, 66.
The confounding effect of obstructive jaundice in the interpretation of proteomic plasma profiling data for pancreatic cancer
Yan, L., Tonack, S., Smith, R., Dodd, S., Jenkins, R., Kitteringham, N., . . . Costello, E. (2009). The confounding effect of obstructive jaundice in the interpretation of proteomic plasma profiling data for pancreatic cancer. Journal of Proteome Research, 8, 142-148.
2008
Complications and follow-up after pancreas-preserving total duodenectomy for duodenal polyps.
Al-Sarireh, B., Ghaneh, P., Gardner-Thorpe, J., Raraty, M., Hartley, M., Sutton, R., & Neoptolemos, J. P. (2008). Complications and follow-up after pancreas-preserving total duodenectomy for duodenal polyps.. The British journal of surgery, 95(12), 1506-1511. doi:10.1002/bjs.6412
Preoperative resolution of jaundice following biliary stenting predicts more favourable early survival in resected pancreatic ductal adenocarcinoma.
Smith, R. A., Dajani, K., Dodd, S., Whelan, P., Raraty, M., Sutton, R., . . . Ghaneh, P. (2008). Preoperative resolution of jaundice following biliary stenting predicts more favourable early survival in resected pancreatic ductal adenocarcinoma.. Annals of surgical oncology, 15(11), 3138-3146. doi:10.1245/s10434-008-0148-z
New treatment options for advanced pancreatic cancer.
Middleton, G., Ghaneh, P., Costello, E., Greenhalf, W., & Neoptolemos, J. P. (2008). New treatment options for advanced pancreatic cancer.. Expert review of gastroenterology & hepatology, 2(5), 673-696. doi:10.1586/17474124.2.5.673
Biology and management of pancreatic cancer
Ghaneh, P., Costello, E., & Neoptolemos, J. P. (2007). Biology and management of pancreatic cancer. GUT, 56(8), 1134-1152. doi:10.1136/gut.2006.103333
Liver resection for colorectal liver metastases in older patients.
de Liguori Carino, N., van Leeuwen, B. L., Ghaneh, P., Wu, A., Audisio, R. A., & Poston, G. J. (2008). Liver resection for colorectal liver metastases in older patients.. Critical reviews in oncology/hematology, 67(3), 273-278. doi:10.1016/j.critrevonc.2008.05.003
Preoperative CA19-9 levels and lymph node ratio are independent predictors of survival in patients with resected pancreatic ductal adenocarcinoma
Smith, R. A., Bosonnet, L., Ghaneh, P., Raraty, M., Sutton, R., Campbell, F., & Neoptolemos, J. P. (2008). Preoperative CA19-9 levels and lymph node ratio are independent predictors of survival in patients with resected pancreatic ductal adenocarcinoma. DIGESTIVE SURGERY, 25(3), 226-232. doi:10.1159/000140961
Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio
Smith, R. A., Ghaneh, P., Sutton, R., Raraty, M., Campbell, F., & Neoptolemos, J. P. (2008). Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio. JOURNAL OF GASTROINTESTINAL SURGERY, 12(8), 1422-1428. doi:10.1007/s11605-008-0554-3
Anterior abdominal wall abscess secondary to subcutaneous gallstones.
Murphy, J. A., Vimalachandran, C. D., Howes, N., & Ghaneh, P. (2008). Anterior abdominal wall abscess secondary to subcutaneous gallstones.. Case reports in gastroenterology, 2(2), 219-223. doi:10.1159/000137375
Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison
Sultana, A., Ghaneh, P., Cunningham, D., Starling, N., Neoptolemos, J. P., & Smith, C. T. (2008). Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison. BMC CANCER, 8. doi:10.1186/1471-2407-8-192
Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses.
Sultana, A., Tudur Smith, C., Cunningham, D., Starling, N., Neoptolemos, J. P., & Ghaneh, P. (2008). Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses.. British journal of cancer, 99(1), 6-13. doi:10.1038/sj.bjc.6604436
The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer
Smith, R. A., Bosonnet, L., Ghaneh, P., Sutton, R., Evans, J., Healey, P., . . . Neoptolemos, J. P. (2008). The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer. SURGERY, 143(5), 658-666. doi:10.1016/j.surg.2007.12.014
Carbohydrate antigen 19.9 accurately selects patients for laparoscopic assessment to determine resectability of pancreatic malignancy
Halloran, C. M., Ghaneh, P., Connor, S., Sutton, R., Neoptolemos, J. P., & Raraty, M. G. T. (2008). Carbohydrate antigen 19.9 accurately selects patients for laparoscopic assessment to determine resectability of pancreatic malignancy. BRITISH JOURNAL OF SURGERY, 95(4), 453-459. doi:10.1002/bjs.6043
Neoadjuvant and adjuvant strategies for pancreatic cancer.
Ghaneh, P., Smith, R., Tudor-Smith, C., Raraty, M., & Neoptolemos, J. P. (2008). Neoadjuvant and adjuvant strategies for pancreatic cancer.. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 34(3), 297-305. doi:10.1016/j.ejso.2007.07.204
Direct activation of cytosolic Ca<SUP>2+</SUP> signaling and enzyme secretion by cholecystokinin in human pancreatic acinar cells
Murphy, J. A., Criddle, D. N., Sherwood, M., Chvanov, M., Mukherjee, R., McLaughlin, E., . . . Sutton, R. (2008). Direct activation of cytosolic Ca<SUP>2+</SUP> signaling and enzyme secretion by cholecystokinin in human pancreatic acinar cells. GASTROENTEROLOGY, 135(2), 632-641. doi:10.1053/j.gastro.2008.05.026
Gemcitabine-Based Combination Chemotherapy in the Treatment of Advanced Pancreatic Cancer
Sultana, A., Neoptolemos, J. P., Frauscher, F., & Ghaneh, P. (2008). Gemcitabine-Based Combination Chemotherapy in the Treatment of Advanced Pancreatic Cancer. American Journal of Hematology and Oncology, 7, 96-100.
2007
Adjuvant chemotherapy—the standard after resection for pancreatic cancer
Ghaneh, P., & Neoptolemos, J. (2007). Adjuvant chemotherapy—the standard after resection for pancreatic cancer. The American Journal of Surgery, 194(4), S131-S137. doi:10.1016/j.amjsurg.2007.05.021
Both HIV- and EIAV-based lentiviral vectors mediate gene delivery to pancreatic cancer cells and human pancreatic primary patient xenografts
Saraga, G., Mafficini, A., Ghaneh, P., Sorio, C., & Costello, E. (2007). Both HIV- and EIAV-based lentiviral vectors mediate gene delivery to pancreatic cancer cells and human pancreatic primary patient xenografts. CANCER GENE THERAPY, 14(9), 781-790. doi:10.1038/sj.cgt.7701066
A new approach to managing intraductal papillary mucinous pancreatic neoplasms.
Ghaneh, P., & Neoptolemos, J. (2007). A new approach to managing intraductal papillary mucinous pancreatic neoplasms.. Gut, 56(8), 1041-1044. doi:10.1136/gut.2006.113068
Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer
Sultana, A., Smith, C. T., Cunningham, D., Starling, N., Neoptolemos, J. P., & Ghaneh, P. (2007). Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer. JOURNAL OF CLINICAL ONCOLOGY, 25(18), 2607-2615. doi:10.1200/JCO.2006.09.2551
Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy.
Sultana, A., Tudur Smith, C., Cunningham, D., Starling, N., Tait, D., Neoptolemos, J. P., & Ghaneh, P. (2007). Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy.. British journal of cancer, 96(8), 1183-1190. doi:10.1038/sj.bjc.6603719
COMPLICATIONS OF PANCREATIC SURGERY
Alexakis, N., Connor, S., Ghaneh, P., Sutton, R., Evans, J. C., & Neoptolemos, J. P. (2007). COMPLICATIONS OF PANCREATIC SURGERY. In Surgical Complications (pp. 421-466). PUBLISHED BY IMPERIAL COLLEGE PRESS AND DISTRIBUTED BY WORLD SCIENTIFIC PUBLISHING CO.. doi:10.1142/9781860948329_0013
Comment on "Adjuvant Therapy in Pancreatic Cancer: A Critical Appraisal"
Ghaneh, P., Tudur-Smith, C., & Neoptolemos, J. P. (2007). Comment on "Adjuvant Therapy in Pancreatic Cancer: A Critical Appraisal". DRUGS, 67(17), 2487-2490. doi:10.2165/00003495-200767170-00002
Complications of pancreatic surgery
Alexakis, N., Connor, S., Ghaneh, P., Sutton, R., Evans, J. C., & Neoptolemos, J. P. (2007). Complications of pancreatic surgery. In N. S. Hakim, & V. E. Papalois (Eds.), Surgical complications: diagnosis and treatment (pp. xxx). London: Imperial College Press.
Epidemiology of pancreatic cancer
Alexakis, N., Ghaneh, P., & Neoptolemos, J. P. (2007). Epidemiology of pancreatic cancer. In H. G. Beger, M. Buchler, R. Kozarek, M. Lerch, J. Neoptolemos, A. Warshaw, . . . K. Shiratori (Eds.), The Pancreas (pp. ??). Eastbourne: Blackwell.
Factors involved in carcinogenesis and prevention in hepatobiliarycancer
Ghaneh, P., Greenhalf, W., & Neoptolemos, J. P. (2007). Factors involved in carcinogenesis and prevention in hepatobiliarycancer. In J. Jankowski, R. E. Sampliner, D. Kerr, & Y. Fong (Eds.), Structure of GI Oncology: A Critical MDT Approach (pp. ??). Oxford: Blackwell Publishing.
Neoadjuvant and adjuvant strategies for pancreatic cancer.
Ghaneh, P., Smith, R., Tudor-Smith, C., Raraty, M., & Neoptolemos, J. P. (2007). Neoadjuvant and adjuvant strategies for pancreatic cancer.. European Journal of Surgical Oncology. Retrieved from http://www.sciencedirect.com/
When is pancreatitis considered to be of biliary origin and what are the implications for management?
Alexakis, N., Lombard, M., Raraty, M., Ghaneh, P., Smart, H. L., Gilmore, I., . . . Neoptolemos, J. P. (2007). When is pancreatitis considered to be of biliary origin and what are the implications for management?. PANCREATOLOGY, 7(2-3), 131-141. doi:10.1159/000104238
2006
The case for adjuvant chemotherapy in pancreatic cancer.
Ghaneh, P., Sultana, A., Shore, S., Stocken, D., & Neoptolemos, J. (2006). The case for adjuvant chemotherapy in pancreatic cancer.. Best practice & research. Clinical gastroenterology, 20(2), 383-401. doi:10.1016/j.bpg.2005.11.008
The inherited genetics of pancreatic cancer and prospects for secondary screening.
Vitone, L. J., Greenhalf, W., McFaul, C. D., Ghaneh, P., & Neoptolemos, J. P. (2006). The inherited genetics of pancreatic cancer and prospects for secondary screening.. Best practice & research. Clinical gastroenterology, 20(2), 253-283. doi:10.1016/j.bpg.2005.10.007
Cancer Stats
Ghaneh, P., & Neoptolemos, J. P. (2006). Cancer Stats. London: Cancer Research UK.
Trattamento miniinvasivo della pancreatite acuta necrotizzante.
Raraty, M. G. T., Connor, S., Evans, J., Ghaneh, P., Sutton, R., & Neoptolemos, J. P. (2006). Trattamento miniinvasivo della pancreatite acuta necrotizzante.. In S. Pedrazzoli (Ed.), Nuovo Trattato di Tecnica Chirurgica Pancreas - Peritoneo - Retroperitoneo - Surrene - Milza (pp. 183-187). Milano: UTET.
2005
Positron emission tomography does not add to computed tomography for the diagnosis and staging of pancreatic cancer.
Lytras, D., Connor, S., Bosonnet, L., Jayan, R., Evans, J., Hughes, M., . . . Neoptolemos, J. P. (2005). Positron emission tomography does not add to computed tomography for the diagnosis and staging of pancreatic cancer.. Digestive surgery, 22(1-2), 55-62. doi:10.1159/000085347
Serum CA19-9 measurement increases the effectiveness of staging laparoscopy in patients with suspected pancreatic malignancy
Connor, S., Bosonnet, L., Alexakis, N., Raraty, M., Ghaneh, P., Sutton, R., & Neoptolemos, J. P. (2005). Serum CA19-9 measurement increases the effectiveness of staging laparoscopy in patients with suspected pancreatic malignancy. DIGESTIVE SURGERY, 22(1-2), 80-85. doi:10.1159/000085297
Adjuvant and neoadjuvant treatment of resectable pancreatic cancer: what is worth attempting?
Raraty, M. G. T., Ghaneh, P., & Neoptolemos, J. P. (2005). Adjuvant and neoadjuvant treatment of resectable pancreatic cancer: what is worth attempting?. In J. E. Dominguez-Munoz (Ed.), Clinical Pancreatology for practising gastroenterologists and surgeons (pp. 444-454). Malden, Massachusetts: Blackwell.
Adjuvant therapy of pancreatic cancer
Ghaneh, P., & Neoptolemos, J. P. (2005). Adjuvant therapy of pancreatic cancer. In E. al (Ed.), Exocrine Pancreatic Cancer. The European Pancreatic Cancer- Research Cooperative (EPC-RC) (pp. 364-381). Hannover: Felsenstein CCCP.
Early and late complications after pancreatic necrosectomy
Connor, S., Alexakis, N., Raraty, M. G. T., Ghaneh, P., Evans, J., Hughes, M., . . . Neoptolemos, J. P. (2005). Early and late complications after pancreatic necrosectomy. SURGERY, 137(5), 499-505. doi:10.1016/j.surg.2005.01.003
Hepatic Metastases
Hugh, T. J., Ghaneh, P., & Poston, G. J. (2005). Hepatic Metastases. In O. J. Garden (Ed.), A Companion Series in Surgical Practice: Hepatobiliary and Pancreatic Surgery. (pp. 97-130). Philadelphia: Elsevier Saunders Ltd.
Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial.
Bassi, C., Stocken, D. D., Olah, A., Friess, H., Buckels, J., Hickey, H., . . . European Study Group for Pancreatic Cancer (ESPAC). (2005). Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial.. Digestive surgery, 22(5), 353-363. doi:10.1159/000089771
Pancreatic Exocrine Tumors
Ghaneh, P., & Neoptolemos, J. P. (2005). Pancreatic Exocrine Tumors. In W. M. Weinstein, C. J. Hawkey, & J. Bosch (Eds.), Clinical Gastroenterology and Hepatology. (pp. 521-534). Edinburgh: Elsevier Limited.
Pancreatic exocrine tumours
Ghaneh, P., & Neoptolemos, J. P. (2005). Pancreatic exocrine tumours. In W. M. Weinstein, C. J. Hawkey, & J. Bosch (Eds.), Clinical Gastroenterology and Hepatology (pp. 521-533). London: Elsevier Mosby.
Positron emission tomography does not add to computed tomography for the diagnosis and staging of pancreatic cancer
Lytras, D., Connor, S., Bosonnet, L., Jayan, R., Evans, J., Hughes, M., . . . Neoptolemos, J. P. (2005). Positron emission tomography does not add to computed tomography for the diagnosis and staging of pancreatic cancer. DIGESTIVE SURGERY, 22(1-2), 55-61. doi:10.1159/000085347
SURGERY IN THE TREATMENT OF ACUTE PANCREATITIS - MINIMAL ACCESS PANCREATIC NECROSECTOMY
Connor, S., Raraty, M. G. T., Howes, N., Evans, J., Ghaneh, P., Sutton, R., & Neoptolemos, J. P. (2005). SURGERY IN THE TREATMENT OF ACUTE PANCREATITIS - MINIMAL ACCESS PANCREATIC NECROSECTOMY. SCANDINAVIAN JOURNAL OF SURGERY, 94(2), 135-142. doi:10.1177/145749690509400210
Trials of gene therapy for pancreatic carcinoma.
Halloran, C. M., Ghaneh, P., Costello, E., & Neoptolemos, J. P. (2005). Trials of gene therapy for pancreatic carcinoma.. Current gastroenterology reports, 7(3), 165-169. doi:10.1007/s11894-005-0028-7
Trials of gene therapy for pancreatic carcinoma.
Halloran, C. M., Ghaneh, P., Costello, E., & Neoptolemos, J. P. (2005). Trials of gene therapy for pancreatic carcinoma.. Curr Gastroenterol Rep, 7, 165-169.
2004
Survival of patients with periampullary carcinoma is predicted by lymph node 8a but not by lymph node 16b1 status
Connor, S., Bosonnet, L., Ghaneh, P., Alexakis, N., Hartley, M., Campbell, F., . . . Neoptolemos, J. P. (2004). Survival of patients with periampullary carcinoma is predicted by lymph node 8a but not by lymph node 16b1 status. BRITISH JOURNAL OF SURGERY, 91(12), 1592-1599. doi:10.1002/bjs.4761
Fungal infection but not type of bacterial infection is associated with a high mortality in primary and secondary infected pancreatic necrosis
Connor, S., Alexakis, N., Neal, T., Raraty, M., Ghaneh, P., Evans, J., . . . Neoptolemos, J. P. (2004). Fungal infection but not type of bacterial infection is associated with a high mortality in primary and secondary infected pancreatic necrosis. DIGESTIVE SURGERY, 21(4), 297-304. doi:10.1159/000080884
Laparoscopy and laparoscopic ultrasound in the evaluation of pancreatic and periampullary tumours
Doran, H. E., Bosonnet, L., Connor, S., Jones, L., Garvey, C., Hughes, M., . . . Sutton, R. (2004). Laparoscopy and laparoscopic ultrasound in the evaluation of pancreatic and periampullary tumours. DIGESTIVE SURGERY, 21(4), 305-313. doi:10.1159/000080885
Current standards of surgery for pancreatic cancer
Alexakis, N., Halloran, C., Raraty, M., Ghaneh, P., Sutton, R., & Neoptolemos, J. P. (2004). Current standards of surgery for pancreatic cancer. BRITISH JOURNAL OF SURGERY, 91(11), 1410-1427. doi:10.1002/bjs.4794
Influence of opioid use on surgical and long-term outcome after resection for chronic pancreatitis
Alexakis, N., Connor, S., Ghaneh, P., Raraty, M., Lombard, M., Smart, H., . . . Neoptolemos, J. P. (2004). Influence of opioid use on surgical and long-term outcome after resection for chronic pancreatitis. SURGERY, 136(3), 600-608. doi:10.1016/j.surg.2004.02.011
Major resection for chronic pancreatitis in patients with vascular involvement is associated with increased postoperative mortality
Alexakis, N., Sutton, R., Raraty, M., Connor, S., Ghaneh, P., Hughes, M. L., . . . Neoptolemos, J. P. (2004). Major resection for chronic pancreatitis in patients with vascular involvement is associated with increased postoperative mortality. BRITISH JOURNAL OF SURGERY, 91(8), 1020-1026. doi:10.1002/bjs.4616
5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16<SUP>INK4A</SUP> greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells
Halloran, C. M., Ghaneh, P., Shore, S., Greenhalf, W., Zumstein, L., Wilson, D., . . . Costello, E. (2004). 5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16<SUP>INK4A</SUP> greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells. JOURNAL OF GENE MEDICINE, 6(5), 514-525. doi:10.1002/jgm.540
Cancer in the elderly: pancreatic cancer
Shore, S., Vimalachandran, D., Raraty, M. G. T., & Ghaneh, P. (2004). Cancer in the elderly: pancreatic cancer. SURGICAL ONCOLOGY-OXFORD, 13(4), 201-210. doi:10.1016/j.suronc.2004.11.001
Diagnosis, treatment and outcome of pancreatoblastoma
Dhebri, A. R., Connor, S., Campbell, F., Ghaneh, P., Sutton, R., & Neoptolemos, J. P. (2004). Diagnosis, treatment and outcome of pancreatoblastoma. PANCREATOLOGY, 4(5), 441-451. doi:10.1159/000079823
Genetics and prevention of pancreatic cancer.
Vimalachandran, D., Ghaneh, P., Costello, E., & Neoptolemos, J. P. (2004). Genetics and prevention of pancreatic cancer.. Cancer control : journal of the Moffitt Cancer Center, 11(1), 6-14. doi:10.1177/107327480401100102
Hereditary pancreatic endocrine tumours
Alexakis, N., Connor, S., Ghaneh, P., Lombard, M., Smart, H. L., Evans, J., . . . Neoptolemos, J. P. (2004). Hereditary pancreatic endocrine tumours. PANCREATOLOGY, 4(5), 417-433. doi:10.1159/000079616
2003
Surgery for midgut carcinoid
Sutton, R., Doran, H. E., Williams, E. M. I., Vora, J., Vinjamuri, S., Evans, J., . . . Neoptolemos, J. P. (2003). Surgery for midgut carcinoid. ENDOCRINE-RELATED CANCER, 10(4), 469-481. doi:10.1677/erc.0.0100469
Increasing age and APACHE II scores are the main determinants of outcome from pancreatic necrosectomy
Connor, S., Ghaneh, P., Raraty, M., Rosso, E., Hartley, M. N., Garvey, C., . . . Neoptolemos, J. P. (2003). Increasing age and APACHE II scores are the main determinants of outcome from pancreatic necrosectomy. BRITISH JOURNAL OF SURGERY, 90(12), 1542-1548. doi:10.1002/bjs.4341
Duodenum- and spleen-preserving total pancreatectomy for end-stage chronic pancreatitis
Alexakis, N., Ghaneh, P., Connor, S., Raraty, M., Sutton, R., & Neoptolemos, J. P. (2003). Duodenum- and spleen-preserving total pancreatectomy for end-stage chronic pancreatitis. BRITISH JOURNAL OF SURGERY, 90(11), 1401-1408. doi:10.1002/bjs.4324
Pancreatic pseudocyst in chronic pancreatitis: endoscopic and surgical treatment.
Rosso, E., Alexakis, N., Ghaneh, P., Lombard, M., Smart, H. L., Evans, J., & Neoptolemos, J. P. (2003). Pancreatic pseudocyst in chronic pancreatitis: endoscopic and surgical treatment.. Digestive surgery, 20(5), 397-406. doi:10.1159/000072706
Minimally invasive retroperitoneal pancreatic necrosectomy
Connor, S., Ghaneh, P., Raraty, M., Sutton, R., Rosso, E., Garvey, C. J., . . . Neoptolemos, J. P. (2003). Minimally invasive retroperitoneal pancreatic necrosectomy. DIGESTIVE SURGERY, 20(4), 270-277. doi:10.1159/000071184
[Adjuvant and additive therapy for cancer of the pancreas].
Neoptolemos, J. P., Raraty, M. G. T., Ghaneh, P., Hickey, H., Stocken, D. D., Dunn, J. A., . . . Büchler, M. W. (2003). [Adjuvant and additive therapy for cancer of the pancreas].. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 74(3), 191-201. doi:10.1007/s00104-003-0614-x
Review article: Chemotherapy for pancreatic cancer
Shore, S., Raraty, M. G. T., Ghaneh, P., & Neoptolemos, J. P. (2003). Review article: Chemotherapy for pancreatic cancer. Alimentary Pharmacology and Therapeutics, 18(11-12), 1049-1069. doi:10.1046/j.1365-2036.2003.01781.x
2002
Complications of pancreatic cancer resection
Halloran, C. M., Ghaneh, P., Bosonnet, L., Hartley, M. N., Sutton, R., & Neoptolemos, J. P. (2002). Complications of pancreatic cancer resection. DIGESTIVE SURGERY, 19(2), 138-146. doi:10.1159/000052029
The role of adjuvant therapy for pancreatic cancer.
Magee, C. J., Ghaneh, P., Hartley, M., Sutton, R., & Neoptolemos, J. P. (2002). The role of adjuvant therapy for pancreatic cancer.. Expert opinion on investigational drugs, 11(1), 87-107. doi:10.1517/13543784.11.1.87
Adjuvant Chemotherapy for Pancreatic Cancer
Raraty, M. G. T., Magee, C. J., Ghaneh, P., & Neoptolemos, J. P. (2002). Adjuvant Chemotherapy for Pancreatic Cancer. In J. Permert, M. Herrington, & T. Adrian (Eds.), Controversies in Pancreatology (pp. 226-242). Stockholm: Carlsson Communication.
New techniques and agents in the adjuvant therapy of pancreatic cancer.
Raraty, M. G. T., Magee, C. J., Ghaneh, P., & Neoptolemos, J. P. (2002). New techniques and agents in the adjuvant therapy of pancreatic cancer.. Acta Oncologica, 41(7-8), 582-595.
2001
Molecular pathogenesis of pancreatic ductal adenocarcinoma and clinical implications.
Magee, C. J., Greenhalf, W., Howes, N., Ghaneh, P., & Neoptolemos, J. P. (2001). Molecular pathogenesis of pancreatic ductal adenocarcinoma and clinical implications.. Surgical oncology, 10(1-2), 1-23. doi:10.1016/s0960-7404(01)00016-0
Hepatic intra-arterial delivery of a retroviral vector expressing the cytosine deaminase gene, controlled by the CEA promoter and intraperitoneal treatment with 5-fluorocytosine suppresses growth of colorectal liver metastases.
Humphreys, M. J., Ghaneh, P., Greenhalf, W., Campbell, F., Clayton, T. M., Everett, P., . . . Neoptolemos, J. P. (2001). Hepatic intra-arterial delivery of a retroviral vector expressing the cytosine deaminase gene, controlled by the CEA promoter and intraperitoneal treatment with 5-fluorocytosine suppresses growth of colorectal liver metastases.. Gene therapy, 8(16), 1241-1247. doi:10.1038/sj.gt.3301518
Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivo.
Ghaneh, P., Greenhalf, W., Humphreys, M., Wilson, D., Zumstein, L., Lemoine, N. R., & Neoptolemos, J. P. (2001). Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivo.. Gene therapy, 8(3), 199-208. doi:10.1038/sj.gt.3301394
Adenovirus-mediated transfer of p53 and p16INK4a results in pancreatic cancer regression in vitro and in vivo
Ghaneh, P., Greenhalf, W., Humphreys, M., Wilson, D., Zumstein, L., Lemoine, N. R., & Neoptolemos, J. P. (2001). Adenovirus-mediated transfer of p53 and p16INK4a results in pancreatic cancer regression in vitro and in vivo. Gene Therapy, 8(3), 199-208. doi:10.1038/sj.gt.3301394
Adjuvant therapy in pancreatic cancer.
Ghaneh, P., Slavin, J., Sutton, R., Hartley, M., & Neoptolemos, J. P. (2001). Adjuvant therapy in pancreatic cancer.. World journal of gastroenterology, 7(4), 482-489. doi:10.3748/wjg.v7.i4.482
Management of necrotizing pancreatitis.
Slavin, J., Ghaneh, P., Sutton, R., Hartley, M., Rowlands, P., Garvey, C., . . . Neoptolemos, J. (2001). Management of necrotizing pancreatitis.. World journal of gastroenterology, 7(4), 476-481. doi:10.3748/wjg.v7.i4.476
2000
Adjuvant therapy for pancreatic cancer.
Ghaneh, P., Slavin, J., Sutton, R., & Neoptolemos, J. P. (2000). Adjuvant therapy for pancreatic cancer.. Swiss surgery = Schweizer Chirurgie = Chirurgie suisse = Chirurgia svizzera, 6(5), 289-295. doi:10.1024/1023-9332.6.5.289
Gene therapy for pancreatic cancer - current and prospective strategies
Halloran, C. M., Ghaneh, P., Neoptolemos, J. P., & Costello, E. (2000). Gene therapy for pancreatic cancer - current and prospective strategies. SURGICAL ONCOLOGY-OXFORD, 9(4), 181-191. doi:10.1016/S0960-7404(01)00011-1
Pylorus-preserving Kausch-Whipple resection: the successor of the classical Kausch-Whipple in chronic pancreatitis.
Slavin, J., Ghaneh, P., Sutton, R., & Neoptolemos, J. P. (2000). Pylorus-preserving Kausch-Whipple resection: the successor of the classical Kausch-Whipple in chronic pancreatitis.. Annali italiani di chirurgia, 71(1), 57-64.
1999
Pancreatic disease: recent advances
Sutton, R., Slavin, J. P., Ghaneh, P., & Neoptolemos, J. P. (1999). Pancreatic disease: recent advances. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 11(1), 33-36. doi:10.1097/00042737-199901000-00007
The future of surgery for pancreatic cancer.
Slavin, J., Ghaneh, P., Jones, L., Sutton, R., Hartley, M., & Neoptolemos, J. P. (1999). The future of surgery for pancreatic cancer.. Annals of oncology : official journal of the European Society for Medical Oncology, 10 Suppl 4, 285-290. doi:10.1023/a:1008349406118
The potential for gene therapy in pancreatic cancer.
Humphreys, M. J., Greenhalf, W., Neoptolemos, J. P., & Ghaneh, P. (1999). The potential for gene therapy in pancreatic cancer.. International journal of pancreatology : official journal of the International Association of Pancreatology, 26(1), 5-21. doi:10.1385/ijgc:26:1:5